CIVETTINI, IVAN
CIVETTINI, IVAN
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies
2024 Malighetti, F; Villa, M; Mauri, M; Piane, S; Crippa, V; Crespiatico, I; Cocito, F; Bossi, E; Steidl, C; Civettini, I; Scollo, C; Ramazzotti, D; Gambacorti-Passerini, C; Piazza, R; Mologni, L; Aroldi, A
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients
2024 Zappaterra, A; Civettini, I; Cafro, A; Pezzetti, L; Pierini, S; Anghilieri, M; Bellio, L; Bertazzoni, P; Grillo, G; Minga, P; Pioltelli, M; Ravano, E; Sassone, M; Viganò, C; Volpato, E; Gambacorti-Passerini, C; Rossini, S; Cairoli, R; Crocchiolo, R
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype
2024 Civettini, I; Zappaterra, A; Corti, P; Messina, A; Aroldi, A; Biondi, A; Cavalca, F; Crippa, V; Crosti, F; Ferrari, G; Malighetti, F; Mologni, L; Piperno, A; Ramazzotti, D; Scollo, C; Zambon, A; Rossi, F; Gambacorti-Passerini, C
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer
2024 Crippa, V; Fontana, D; Civettini, I; Mologni, L; Piazza, R; Gambacorti Passerini, C; Ramazzotti, D
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia
2023 Inzoli, E; Crisa, E; Pugliese, N; Civettini, I; Lanzarone, G; Castelli, A; Martinelli, V; Montelisciani, L; Antolini, L; Gambacorti-Passerini, C; Elli, E
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
2023 Malighetti, F; Arosio, G; Manfroni, C; Mauri, M; Villa, M; Manghisi, B; Inzoli, E; Rindone, G; Zambrotta, G; Civettini, I; Guglielmana, V; Ramazzotti, D; Giudici, G; Bombelli, S; Perego, R; Piazza, R; Mologni, L; Gambacorti-Passerini, C
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making
2023 Civettini, I; Zappaterra, A; Granelli, B; Rindone, G; Aroldi, A; Bonfanti, S; Colombo, F; Fedele, M; Grillo, G; Parma, M; Perfetti, P; Terruzzi, E; Gambacorti-Passerini, C; Ramazzotti, D; Cavalca, F
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C